Nicotine-induced expression of low-density lipoprotein receptor in oral epithelial cells

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Ito, Satoshi ^a   Gojoubori, Takahiro ^a   Tsunoda, Kou ^a   Yamaguchi, Yoko ^a   Asano, Masatake ^a   Goke, Eiji ^a   Koshi, Ryosuke ^a   Sugano, Naoyuki ^a   Yoshinuma, Naoto ^a   Komiyama, Kazuo ^a   Ito, Koichi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; TRANSCRIPTION FACTOR SP1;

ADULT; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; LIPID METABOLISM; LOW DENSITY LIPOPROTEIN RECEPTOR GENE; MALE; MIDDLE AGED; MOUTH MUCOSA; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ADULT; AGED; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; FEMALE; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; MOUTH MUCOSA; NICOTINE; RECEPTORS, LDL; UP-REGULATION;

EID: 84892777043     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082563     Document Type: Article

References (56)

1. van der Heide F, Dijkstra A, Weersma RK, Albersnagel FA, van der Logt EM et al. (2009) Effects of active and passive smoking on disease course of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 15: 1199-1207. doi:10.1002/ibd.20884. PubMed: 19170191.
2. Palmer RM, Wilson RF, Hasan AS, Scott DA (2005) Mechanisms of action of environmental factors - tobacco smoking. J Clin Periodontol 32 Suppl 6: 180-195. doi:10.1111/j.1600-051X.2005.00786.x. PubMed: 16128837.
3. Laxman VK, Annaji S (2008) Tobacco use and its effects on the periodontium andperiodontal therapy. J Contemp Dent Pract 9: 97-107.
4. Lee J, Cooke JP (2012) Nicotine and pathological angiogenesis. Life Sci 91: 1058-1064. doi:10.1016/j.lfs.2012.06.032. PubMed: 22796717.
5. Santanam N, Thornhill BA, Lau JK, Crabtree CM, Cook CR et al. (2012) Nicotinic acetylcholine receptor signaling in atherogenesis. Atherosclerosis 225: 264-273. doi:10.1016/j.atherosclerosis.2012.07.041. PubMed: 22929083.
6. Bahekar AA, Singh S, Saha S, Molnar J, Arora R (2007) The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 154: 830-837. doi:10.1016/j.ahj.2007.06.037. PubMed: 17967586.
7. Chelland Campbell S, Moffatt RJ, Stamford BA (2008) Smoking and smoking cessation - the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis 201: 225-235. doi:10.1016/j. atherosclerosis.2008.04.046. PubMed: 18565528.
8. Katz J, Flugelman MY, Goldberg A, Heft M (2002) Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels. J Periodontol 73: 494-500. doi:10.1902/jop.2002.73.5.494. PubMed: 12027250.
9. Lösche W, Karapetow F, Pohl A, Pohl C, Kocher T (2000) Plasma lipid and blood glucose levels in patients with destructive periodontal disease. J Clin Periodontol 27: 537-541. doi:10.1034/j.1600-051x.2000.027008537.x. PubMed: 10959778.
10. Sakiyama Y, Kato R, Inoue S, Suzuki K, Itabe H et al. (2010) Detection of oxidized low-density lipoproteins in gingival crevicular fluid from dental patients. J Periodontal Res 45: 216-222. doi:10.1111/j.1600-0765.2009.01226.x. PubMed: 19778326.
11. Noack B, Jachmann I, Roscher S, Sieber L, Kopprasch S et al. (2000) Metabolic diseases andtheir possible link to risk indicators of periodontitis. J Periodontol 71: 898-903. doi:10.1902/jop.2000.71.6.898. PubMed: 10914792.
12. Suzuki K, Sakiyama Y, Usui M, Obama T, Kato R et al. (2010) Oxidized low-density lipoprotein increases interleukin-8 production in human gingival epithelial cell line Ca9-22. J Periodontal Res 45: 488-495. PubMed: 20412422.
13. Yildiz D (2004) Nicotine, its metabolism and an overview of its biological effects. Toxicon 43: 619-632. doi:10.1016/j.toxicon.2004.01.017. PubMed: 15109883.
14. Kashiwagi Y, Yanagita M, Kojima Y, Shimabukuro Y, Murakami S (2012) Nicotine up-regulates IL-8 expression in human gingival epithelial cells following stimulation with IL-1beta or P. gingivalis lipopolysaccharide via nicotinic acetylcholine receptor signalling. Arch Oral Biol 57: 483-490. doi:10.1016/j.archoralbio.2011.10.007. PubMed: 22119045.
15. Mahanonda R, Sa-Ard-Iam N, Eksomtramate M, Rerkyen P, Phairat B, et al. (2009) Cigarette smoke extract modulates human beta-defensin-2 and interleukin-8 expression in human gingival epithelial cells. J Periodontal Res 44: 557-564
16. Johnson GK, Guthmiller JM, Joly S, Organ CC, Dawson DV (2010) Interleukin-1and interleukin-8 in nicotine- and lipopolysaccharide-exposed gingival keratinocyte cultures. J Periodontal Res 45: 583-588. PubMed: 20337880.
17. Koshi R, Sugano N, Namba K, Ohshio K, Ito K (2007) The effects of nicotine on gene expression of the oral epithelial cell line (Ca9-22). Nihon University Dental Journal 81: 571-576.
18. Omagari D, Takenouchi-Ohkubo N, Endo S, Ishigami T, Sawada A et al. (2011) Nuclear factor kappa B plays a pivotal role in polyinosinic-polycytidylic acid-induced expression of human β-defensin 2 inintestinal epithelial cells. Clin Exp Immunol 165: 85-93. PubMed: 21501152.
19. Arredondo J (2006) Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of 7 nicotinic receptor in oral keratinocytes. FASEB J 20: 2093-2101. doi:10.1096/fj.06-6191com. PubMed: 17012261.
20. Arredondo J, Chernyavsky AI, Jolkovsky DL, Pinkerton KE, Grando SA (2007) Receptor-mediated tobacco toxicity: Alterations of the NF-κBexpression and activity downstream of α7 nicotinic receptor in oralkeratinocytes. Life Sci 80: 2191-2194. doi:10.1016/j.lfs.2007.01.013. PubMed: 17291542.
21. Südhof TC, Van der Westhuyzen DR, Goldstein JL, Brown MS, Russell DW (1987) Three direct repeats and a TATA-like sequence are required for regulated expression of the human low density lipoprotein receptor gene. J Biol Chem 262: 10773-10779. PubMed: 3611089.
22. Dawson PA, Hofmann SL, van der Westhuyzen DR, Südhof TC, Brown MS et al. (1988) Sterol-dependent repression of low density lipoprotein receptor promoter mediated by 16-base pair sequence adjacent to binding site for transcription factor Sp1. J Biol Chem 263: 3372-3379. PubMed: 3277969.
23. Blume SW, Snyder RC, Ray R, Thomas S, Koller CA et al. (1991) Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest 88: 1613-1621. doi:10.1172/JCI115474. PubMed: 1834700.
24. Dunckley T, Lukas RJ (2003) Nicotine modulates the expression of a diverse set of genes in the neuronal SH-SY5Y cell line. J Biol Chem 278: 15633-15640. doi:10.1074/jbc.M210389200. PubMed: 12588870.
25. Lax P, Fucile S, Eusebi F (2002) Ca2+ permeability of human heteromeric nAChRs expressed by transfection in human cells. Cell Calcium 32: 53-58. doi:10.1016/S0143-4160(02)00076-3. PubMed: 12161105.
26. Nguyen VT, Hall LL, Gallacher G, Ndoye A, Jolkovsky DL et al. (2000) Choline acetyltransferase, acetylcholinesterase, and nicotinic acetylcholine receptors of human gingival and esophageal epithelia. J Dent Res 79: 939-949. doi:10.1177/00220345000790040901. PubMed: 10831096.
27. Arredondo J, Nguyen VT, Chernyavsky AI, Jolkovsky DL, Pinkerton KE et al. (2001) A receptor-mediated mechanism of nicotine toxicity in oral keratinocytes. Lab Invest81: 1653-1668. doi:10.1038/labinvest.3780379. PubMed: 11742036.
28. Nguyen VT, Ndoye A, Grando SA (2000) Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity. Am J Pathol 157: 1377-1391. doi:10.1016/S0002-9440(10)64651-2. PubMed: 11021840.
29. Arredondo J, Chernyavsky AI, Marubio LM, Beaudet AL, Jolkovsky DL et al. (2005) Receptor-Mediated Tobacco Toxicity. Am J Pathol 166: 597-613. doi:10.1016/S0002-9440(10)62281-X. PubMed: 15681842.
30. Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47. doi:10.1126/science.3513311. PubMed: 3513311.
31. Goldstein JL, DeBose-Boyd RA, Brown MS (2006) Protein sensors for membrane sterols. Cell 124: 35-46. doi:10.1016/j.cell.2005.12.022. PubMed: 16413480.
32. Hobbs HH, Brown MS, Goldstein JL (1992) Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1: 445-466. doi:10.1002/humu.1380010602. PubMed: 1301956.
33. Peeters AV, Kotze MJ, Scholtz CL, De Waal LF, Rubinsztein DC et al. (1998) A 3-basepair deletion in repeat 1 of the LDL receptor promoter reduces transcriptional activity in a South African Pedi. J Lipid Res 39: 1021-1024. PubMed: 9610768.
34. Brown MS, Goldstein JL (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 331-340. doi:10.1016/S0092-8674(00)80213-5. PubMed: 9150132.
35. Smith AJP, Ahmed F, Nair D, Whittall R, Wang D et al. (2007) A functional mutation in the LDLR promoter (-139C>G) in a patient with familial hypercholesterolemia. European Journal of Human Genetics 15: 1186-1189. doi:10.1038/sj.ejhg.5201897. PubMed: 17625505.
36. Li L, Davie JR (2010) The role of Sp1 and Sp3 in normal and cancer cell biology. Ann Anat 192: 275-283. doi:10.1016/j.aanat.2010.07.010. PubMed: 20810260.
37. Chu S (2012) Transcriptional regulation by post-transcriptional modification. Role of phosphorylation in Sp1 transcriptional activity. Gene 508: 1-8. doi:10.1016/j.gene.2012.07.022. PubMed: 22835698.
38. Kuwahara J, Watanabe Y, Kayasuga T, Itoh K (2000) Zn finger and nuclear localization of transcription factor Sp1. Nucleic Acids Symp Ser: 265-266. PubMed: 12903370.
39. Ito T, Kitamura H, Uwatoko C, Azumano M, Itoh K et al. (2010) Interaction of Sp1 zinc finger with transport factor in the nuclear localization of transcription factor Sp1. Biochem Biophys Res Commun 403: 161-166. doi:10.1016/j.bbrc.2010.10.036. PubMed: 20946882.
40. Campos-Caro A, Carrasco-Serrano C, Valor LM, Ballesta JJ, Criado M (2001) Activity of the nicotinic acetylcholine receptor alpha5 and alpha7 subunit promoters in muscle cells. DNA Cell Biol 20: 657-666. doi:10.1089/ 104454901753340640. PubMed: 11749724.
41. Scofield MD, Tapper AR, Gardner PD (2010) A transcriptional regulatory element critical for CHRNB4 promoter activity in vivo. Neuroscience 170: 1056-1064. doi:10.1016/j.neuroscience.2010.08.007. PubMed: 20696214.
42. Campos-Caro A, Carrasco-Serrano C, Valor LM, Viniegra S, Ballesta JJ et al. (1999) Multiple functional Sp1 domains in the minimal promoter region of the neuronal nicotinic receptor alpha5 subunit gene. J Biol Chem 274: 4693-4701. doi:10.1074/jbc.274.8.4693. PubMed: 9988706.
43. Yang X, Fyodorov D, Deneris ES (1995) Transcriptional analysis of acetylcholine receptor alpha 3 gene promoter motifs that bind Sp1 and AP2. J Biol Chem 270: 8514-8520. doi:10.1074/jbc.270.15.8514. PubMed: 7721749.
44. Bigger CB, Casanova EA, Gardner PD (1996) Transcriptional regulation of neuronal nicotinic acetylcholine receptor genes. Functional interactions between Sp1 and the rat beta4 subunit gene promoter. J Biol Chem 271: 32842-32848. doi:10.1074/jbc.271.51.32842. PubMed: 8955122.
45. Bigger CB, Melnikova IN, Gardner PD (1997) Sp1 and Sp3 regulate expression of the neuronal nicotinic acetylcholine receptor beta4 subunit gene. J Biol Chem 272: 25976-25982. doi:10.1074/jbc.272.41.25976. PubMed: 9325332.
46. Li L, He S, Sun JM, Davie JR (2004) Gene regulation by Sp1 and Sp3. Biochem Cell Biol 82: 460-471. doi:10.1139/o04-045. PubMed: 15284899.
47. Melnikova IN, Gardner PD (2001) The signal transduction pathway underlying ion channel gene regulation by SP1-C-Jun interactions. J Biol Chem 276: 19040-19045. doi:10.1074/jbc.M010735200. PubMed: 11262397.
48. Melnikova IN, Lin HR, Blanchette AR, Gardner PD (2000) Synergistic transcriptional activation by Sox10 and Sp1 family members. Neuropharmacology 39: 2615-2623. doi:10.1016/S0028-3908(00)00125-8. PubMed: 11044731.
49. Valor LM, Campos-Caro A, Carrasco-Serrano C, Ortiz JA, Ballesta JJ et al. (2002) Transcription factors NF-Y and Sp1 are important determinants of the promoter activity of the bovine and human neuronal nicotinic receptor beta 4 subunit genes. J Biol Chem 277: 8866-8876. doi:10.1074/jbc.M110454200. PubMed: 11742001.
50. Sun X, Ritzenthaler JD, Zhong X, Zheng Y, Roman J et al. (2009) Nicotine stimulates PPARbeta/delta expression in human lung carcinoma cells through activation of PI3K/mTOR and suppression of AP-2alpha. Cancer Res 69: 6445-6453. doi:10.1158/0008-5472.CAN-09-1001. PubMed: 19654299.
51. Goldstein JL, Brown MS (2009) The LDL Receptor. Arterioscler Thromb Vasc Biol 29: 431-438. doi:10.1161/ATVBAHA.108.179564. PubMed: 19299327.
52. Lau PP, Li L, Merched AJ, Zhang AL, Ko KW et al. (2006) Nicotine induces proinflammatory responses in macrophages and the aorta leading to acceleration of atherosclerosis in low-density lipoprotein receptor(-/-) mice. Arterioscler Thromb Vasc Biol 26: 143-149. doi:10.1161/01.ATV.0000245790.47112.b2. PubMed: 16254210.
53. Booyse FM, Osikowicz G, Quarfoot AJ (1981) Effects of chronic oral consumption of nicotine on the rabbit aortic endothelium. Am J Pathol 102: 229-238. PubMed: 7468769.
54. Ashakumary L, Vijayammal PL (1997) Effect of nicotine on lipoprotein metabolism in rats. Lipids 32: 311-315. doi:10.1007/s11745-997-0038-8. PubMed: 9076668.
55. Chattopadhyay K, Chattopadhyay BD (2008) Effect of nicotine on lipid profile, peroxidation & antioxidant enzymes in female rats with restricted dietary protein. Indian J Med Res 127: 571-576. PubMed: 18765876.
56. Kita T, Kume N, Minami M, Hayashida K, Murayama T et al. (2001) Role of oxidized LDL in atherosclerosis. Ann N Y Acad Sci 947: 196-205; discussion: